Brenda M Birmann1, Mollie E Barnard1, Kimberly A Bertrand1, Ying Bao1, Marta Crous-Bou1, Brian M Wolpin1, Immaculata De Vivo1, Shelley S Tworoger1. 1. Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Abstract
OBJECTIVES: To review the contributions of the Nurses' Health Study (NHS) to epidemiologic knowledge of endometrial, ovarian, pancreatic, and hematologic cancers. METHODS: We reviewed selected NHS publications from 1976 to 2016, including publications from consortia and other pooled studies. RESULTS: NHS studies on less common cancers have identified novel risk factors, such as a reduced risk of endometrial cancer in women of advanced age at last birth, and have clarified or prospectively confirmed previously reported associations, including an inverse association between tubal ligation and ovarian cancer. Through biomarker research, the NHS has furthered understanding of the pathogenesis of rare cancers, such as the role of altered metabolism in pancreatic cancer risk and survival. NHS investigations have also demonstrated the importance of the timing of exposure, such as the finding of a positive association of early life body fatness, but not of usual adult body mass index, with non-Hodgkin lymphoma risk. CONCLUSIONS: Evidence from the NHS has informed prevention strategies and contributed to improved survival from less common but often lethal malignancies, including endometrial, ovarian, pancreatic, and hematologic cancers.
OBJECTIVES: To review the contributions of the Nurses' Health Study (NHS) to epidemiologic knowledge of endometrial, ovarian, pancreatic, and hematologic cancers. METHODS: We reviewed selected NHS publications from 1976 to 2016, including publications from consortia and other pooled studies. RESULTS: NHS studies on less common cancers have identified novel risk factors, such as a reduced risk of endometrial cancer in women of advanced age at last birth, and have clarified or prospectively confirmed previously reported associations, including an inverse association between tubal ligation and ovarian cancer. Through biomarker research, the NHS has furthered understanding of the pathogenesis of rare cancers, such as the role of altered metabolism in pancreatic cancer risk and survival. NHS investigations have also demonstrated the importance of the timing of exposure, such as the finding of a positive association of early life body fatness, but not of usual adult body mass index, with non-Hodgkin lymphoma risk. CONCLUSIONS: Evidence from the NHS has informed prevention strategies and contributed to improved survival from less common but often lethal malignancies, including endometrial, ovarian, pancreatic, and hematologic cancers.
Authors: C S Fuchs; G A Colditz; M J Stampfer; E L Giovannucci; D J Hunter; E B Rimm; W C Willett; F E Speizer Journal: Arch Intern Med Date: 1996-10-28
Authors: Lindsay M Morton; Jennifer J Turner; James R Cerhan; Martha S Linet; Patrick A Treseler; Christina A Clarke; Andrew Jack; Wendy Cozen; Marc Maynadié; John J Spinelli; Adele Seniori Costantini; Thomas Rüdiger; Aldo Scarpa; Tongzhang Zheng; Dennis D Weisenburger Journal: Blood Date: 2007-03-27 Impact factor: 22.113
Authors: S Zhang; D J Hunter; B A Rosner; G A Colditz; C S Fuchs; F E Speizer; W C Willett Journal: J Natl Cancer Inst Date: 1999-10-20 Impact factor: 13.506
Authors: Anne Kricker; Bruce K Armstrong; Ann Maree Hughes; Chris Goumas; Karin Ekström Smedby; Tongzhang Zheng; John J Spinelli; Sylvia De Sanjosé; Patricia Hartge; Mads Melbye; Eleanor V Willett; Nikolaus Becker; Brian C H Chiu; James R Cerhan; Marc Maynadié; Anthony Staines; Pierluigi Cocco; Paolo Boffeta Journal: Int J Cancer Date: 2008-01-01 Impact factor: 7.396
Authors: S E Hankinson; D J Hunter; G A Colditz; W C Willett; M J Stampfer; B Rosner; C H Hennekens; F E Speizer Journal: JAMA Date: 1993-12-15 Impact factor: 56.272
Authors: Jared R Mayers; Chen Wu; Clary B Clish; Peter Kraft; Margaret E Torrence; Brian P Fiske; Chen Yuan; Ying Bao; Mary K Townsend; Shelley S Tworoger; Shawn M Davidson; Thales Papagiannakopoulos; Annan Yang; Talya L Dayton; Shuji Ogino; Meir J Stampfer; Edward L Giovannucci; Zhi Rong Qian; Douglas A Rubinson; Jing Ma; Howard D Sesso; John Michael Gaziano; Barbara B Cochrane; Simin Liu; Jean Wactawski-Wende; JoAnn E Manson; Michael N Pollak; Alec C Kimmelman; Amanda Souza; Kerry Pierce; Thomas J Wang; Robert E Gerszten; Charles S Fuchs; Matthew G Vander Heiden; Brian M Wolpin Journal: Nat Med Date: 2014-09-28 Impact factor: 53.440
Authors: Tsuyoshi Hamada; Chen Yuan; Shuji Ogino; Brian M Wolpin; Ying Bao; Mingfeng Zhang; Natalia Khalaf; Ana Babic; Vicente Morales-Oyarvide; Barbara B Cochrane; J Michael Gaziano; Edward L Giovannucci; Peter Kraft; JoAnn E Manson; Kimmie Ng; Jonathan A Nowak; Thomas E Rohan; Howard D Sesso; Meir J Stampfer; Laufey T Amundadottir; Charles S Fuchs; Immaculata De Vivo Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-19 Impact factor: 4.254
Authors: Tsuyoshi Hamada; Natalia Khalaf; Chen Yuan; Ana Babic; Vicente Morales-Oyarvide; Zhi Rong Qian; Jonathan Andrew Nowak; Kimmie Ng; Peter Kraft; Douglas Adam Rubinson; Meir Jonathan Stampfer; Edward Luciano Giovannucci; Charles Stewart Fuchs; Shuji Ogino; Brian Matthew Wolpin Journal: J Gastroenterol Date: 2018-01-23 Impact factor: 7.527
Authors: Claudia Trudel-Fitzgerald; Elizabeth M Poole; Anil K Sood; Olivia I Okereke; Ichiro Kawachi; Laura D Kubzansky; Shelley S Tworoger Journal: Psychosom Med Date: 2019 Nov/Dec Impact factor: 4.312
Authors: Kristin S Weeks; Charles F Lynch; Michele West; Megan McDonald; Ryan Carnahan; Sherri L Stewart; Mary Charlton Journal: J Rural Health Date: 2020-02-20 Impact factor: 5.667
Authors: Clary B Clish; Shelley S Tworoger; Oana A Zeleznik; A Heather Eliassen; Peter Kraft; Elizabeth M Poole; Bernard A Rosner; Sarah Jeanfavre; Amy A Deik; Kevin Bullock; Daniel S Hitchcock; Julian Avila-Pacheco Journal: Cancer Res Date: 2020-01-22 Impact factor: 12.701
Authors: Tsuyoshi Hamada; Natalia Khalaf; Chen Yuan; Vicente Morales-Oyarvide; Ana Babic; Jonathan A Nowak; Zhi Rong Qian; Kimmie Ng; Douglas A Rubinson; Peter Kraft; Edward L Giovannucci; Meir J Stampfer; Charles S Fuchs; Shuji Ogino; Brian M Wolpin Journal: Clin Gastroenterol Hepatol Date: 2018-02-21 Impact factor: 11.382
Authors: Paula Peremiquel-Trillas; Jon Frias-Gomez; Laia Alemany; Alberto Ameijide; Mireia Vilardell; Rafael Marcos-Gragera; Sònia Paytubi; Jordi Ponce; José Manuel Martínez; Marta Pineda; Joan Brunet; Xavier Matías-Guiu; Marià Carulla; Jaume Galceran; Ángel Izquierdo; Josep M Borràs; Laura Costas; Ramon Clèries Journal: Int J Environ Res Public Health Date: 2022-01-27 Impact factor: 3.390
Authors: Christopher M Wilson; Oscar E Ospina; Mary K Townsend; Jonathan Nguyen; Carlos Moran Segura; Joellen M Schildkraut; Shelley S Tworoger; Lauren C Peres; Brooke L Fridley Journal: Cancers (Basel) Date: 2021-06-17 Impact factor: 6.575